Skip to main content
OpenTrials

Clinical trial condition

Lymphatic Diseases

Explore clinical trials studying Lymphatic Diseases. Study availability and eligibility vary by location and protocol.

19 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

Lymphatic Diseases trial results

Completed

A Safety Trial of Lisocabtagene Maraleucel (JCAR017) for Relapsed and Refractory (R/R) B-cell Non-Hodgkin Lymphoma (NHL) in the Outpatient Setting (TRANSCEND-OUTREACH-007)

NCT03744676

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations
  • Local Institution - 0057 Los Angeles, California, United States
  • Local Institution - 0060 Denver, Colorado, United States
  • Local Institution - 0089 Miami, Florida, United States
  • Local Institution - 0081 Orlando, Florida, United States
View all 23 locations
View Trial Details
Completed

Sildenafil for the Treatment of Lymphatic Malformations

NCT02335242

Conditions
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, +3 more
Locations
  • Stanford University Stanford, California, United States
  • University of Colorado, Denver Aurora, Colorado, United States
  • Ann & Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States
View Trial Details
Completed

Study on the Role of Brentuximab Vedotin as Single Agent in the Treatment of Relapsed/Refractory CD30+ PTCL Patients

NCT02497131

Conditions
Hemic and Lymphatic Diseases, Lymphatic Diseases
Locations
  • Ematologia "L. & A. Seragnoli" - Policlinico S. Orsola Malpighi Bologna, Italy
  • Ematologia e Trapianto IRCCS, Istituto Nazionale dei Tumori Milan, Italy
  • SC Ematologia - Città della Salute e della Scienza Torino, Italy
  • A.O. Universitaria S. Maria Della Misericordia Di Udine Udine, Italy
View Trial Details

Related conditions